Il campionamento bioptico prostatico transrettale ecoguidato iterativo in pazienti con esame istologico negativo.

Translated title of the contribution: Repeated ultrasound-guided transrectal prostate biopsy in patients with negative histologic test

M. Raber, V. Scattoni, A. Salonia, P. Consonni, P. Rigatti

Research output: Contribution to journalArticle

Abstract

The screening programs for prostate cancer will affect a number increasing of patients over 50 years with consequence rising the bioptic demand. Nevertheless the istopathologic results are negatives for carcinoma in the most part of patients. It's evident that a part of carcinomas are lost at biopsy. Two hundred four patients where submitted at second bioptic session after a maximum of 12 months. Our results show a percent probability of positive findings in 12%. In 75% cancer diagnosed in that second session had clinically significance. Prostate specific antigen (PSA) value, in our study, is the most positive predictive parameter for prostate cancer at second biopsy. Patients with PSA > 10 ng/ml have a risk 7 times greater of having a prostatic cancer respect to patients with PSA <10 ng/ml. PSA density, PSA velocity and the presence of ipoecoic areas previously biopsied, aren't risk factors for detection of prostate cancer at second bioptic session.

Translated title of the contributionRepeated ultrasound-guided transrectal prostate biopsy in patients with negative histologic test
Original languageItalian
Pages (from-to)197-199
Number of pages3
JournalArchivio Italiano di Urologia e Andrologia
Volume72
Issue number4
Publication statusPublished - Dec 2000

ASJC Scopus subject areas

  • Nephrology
  • Urology

Fingerprint Dive into the research topics of 'Repeated ultrasound-guided transrectal prostate biopsy in patients with negative histologic test'. Together they form a unique fingerprint.

  • Cite this